Aethlon Medical, Inc. (AEMD)
NASDAQ: AEMD · Real-Time Price · USD
1.225
-0.225 (-15.52%)
At close: Jul 10, 2025, 4:00 PM
1.160
-0.065 (-5.31%)
Pre-market: Jul 11, 2025, 4:46 AM EDT

Aethlon Medical Stock Forecast

AEMD's stock price has decreased by -63.07% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 2 analysts that cover Aethlon Medical stock have a consensus rating of "Buy" and an average price target of $28.75, which forecasts a 2246.94% increase in the stock price over the next year. The lowest target is $1.5 and the highest is $56.

Price Target: $28.75 (+2246.94%)
Analyst Consensus: Buy
Target Low Average Median High
Price $1.50 $28.75 $56 $56
Change +22.45% +2246.9% +4471.4% +4471.4%

Analyst Ratings

The average analyst rating for Aethlon Medical stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Feb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy 111111
Buy 000000
Hold 000001
Sell 000000
Strong Sell 000000
Total 111112

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Initiates
$1.5
Hold Initiates $1.5 +22.45% Jul 7, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong Buy Reiterates $56 +4,471.43% Mar 10, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong Buy Reiterates $56 +4,471.43% Feb 19, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong Buy Reiterates $56 +4,471.43% Jan 30, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$56
Strong Buy Reiterates $56 +4,471.43% Nov 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.65
from -8.58
EPS Next Year
-0.64
from -2.65
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Mar 31, 2021 Mar 31, 2022 Mar 31, 2023 Mar 31, 2024 Mar 31, 2025 Mar 31, 2026 Mar 31, 2027
Revenue
659.10K294.17K574.25K----
Revenue Growth
1.37%-55.37%95.21%----
EPS
-52.18-56.47-46.86-38.87-8.58-2.65-0.64
EPS Growth
-------
Forward PE
-------
No. Analysts
-----53
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20262027
High n/a n/a
Avg n/a n/a
Low n/a n/a

Revenue Growth

Revenue Growth 20262027
High - -
Avg - -
Low - -

EPS Forecast

EPS 20262027
High -1.75 -0.66
Avg -2.65 -0.64
Low -3.46 -0.62

EPS Growth

EPS Growth 20262027
High - -
Avg - -
Low - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.